Virus News and Research

Latest Virus News and Research

Study finds mutational changes in Omicron variant likely increase transmissibility

A new study presented evidence for a large number of mutational changes in the Omicron variant which will likely increase its transmissibility and significantly decrease the neutralization capacity of monoclonal antibodies, leading to a decline in vaccine efficacy.

10 Dec 2021

Mutational landscape of SARS-CoV-2 Omicron variant

New research suggests mutations on the receptor-binding domain of the Omicron variant exert indirect effects that reduce antibody binding to epitopes and promote immune evasion.

10 Dec 2021

Screening FDA-approved compounds shown to possess antiviral or antimicrobial activity for SARS-CoV-2 inhibition

Researchers have screened several compounds that could show the ability to inhibit SARS-CoV-2.

10 Dec 2021

Research suggests targeting fusion peptide-calcium interaction may help treat COVID-19

Researchers discovered that the entry of coronaviruses is a Ca2+-dependent process and focused their studies on the SARS-1 FP-Ca2+ interaction and its effect on membranes using electron spin resonance (ESR).

10 Dec 2021

Study finds sarbecoviruses circulating in wildlife outside Asia can infect human cells

A recent study tested the RBD of 2 sarbecoviruses found in Russian horseshoe bats and other clades 3 viruses for their ability to invade the human cell.

10 Dec 2021

Maternal and neonatal cord-blood antibody profile in response to SARS-CoV-2

The goal of the current research was to determine the profile and specificity of maternal serum and neonatal cord blood antibody responses to SARS-CoV-2 virus exposure in mothers.

10 Dec 2021

Neutralizing antibody response against SARS-CoV-2 variants in health care workers pre- and post-vaccination

Researchers examined neutralizing antibody levels in 48 vaccinated health care workers against the major SARS-CoV-2 variants.

10 Dec 2021

Insight into immune cell communication may pave the way for new cancer vaccines

In the past decade, immunotherapy has helped save the lives of many cancer patients, many with lung cancer, who might have otherwise faced almost certain death sentences.

9 Dec 2021

Analysis finds substantially more mutations in the omicron SARS-CoV-2 variant

A University of Florida Health researcher has successfully analyzed the many mutations in the omicron variant of the SARS-CoV-2 virus, a crucial step in better understanding the variant's potential threat and ways to combat it.

9 Dec 2021

Researchers review transmission, origin, pathogenesis, animal model and diagnosis of Zika virus

Announcing a new article publication for Zoonoses journal. Dallas Vue and Qiyi Tang from Howard University College of Medicine, Washington, DC, USA review transmission, origin, pathogenesis, animal model and diagnosis of Zika Virus.

9 Dec 2021

Booster vaccination can reduce breakthrough infection risk in HIV patients

New study reveals that people with HIV are at a high risk of breakthrough COVID-19 infection in comparison to people without HIV, and that booster vaccinations can be protective for those living with HIV.

9 Dec 2021

Assessing the risk of Omicron variant transmission by travelers from South Africa

A new study led by a multinational team of researchers studied the risk of importation of the Omicron variant by travelers from South Africa.

9 Dec 2021

COVID-19 vaccine-related myocarditis in young people is mild and resolves quickly, research says

Most young people under the age of 21 who developed suspected COVID-19 vaccine-related heart muscle inflammation known as myocarditis had mild symptoms that improved quickly, according to new research published today in the American Heart Association’s flagship journal Circulation.

9 Dec 2021

SARS-CoV-2 Omicron variant may bind with ACE2 receptor more efficiently

A new study discusses the effect of the Omicron variant’s mutations on its binding efficiency to the ACE2 receptor.

9 Dec 2021

Investigational mRNA-based HIV vaccine shows promise in mice and non-human primates

An experimental HIV vaccine based on mRNA—the same platform technology used in two highly effective COVID-19 vaccines—shows promise in mice and non-human primates, according to scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

9 Dec 2021

KHN’s ‘What the Health?’: Much ado about (vaccine) mandates

Even with the new omicron variant of the covid virus spreading in the U.S., Republicans on Capitol Hill are pushing to stop President Joe Biden from requiring workers to either be tested regularly or vaccinated.

9 Dec 2021

Novel waveform-based approach to determine the propensity of betacoronaviruses to infect humans

Scientists attempt to understand the evolution of the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2.

9 Dec 2021

Study of individuals referred to a cardiovascular disease clinic designed for patients with long COVID

Scientists discuss the characteristics, diagnostic evaluations, and cardiac diagnoses in patients referred to a clinic designed for patients with PASC.

9 Dec 2021

Study reveals the role of intracellular receptor PQBP1 in response to Tau protein

Just as a home security system can alert a homeowner to the presence of an intruder, a protein called polyglutamine binding protein-1 (PQBP1) found in brain cells can alert the body to the presence of "intruding" viruses like human immunodeficiency virus (HIV).

9 Dec 2021

Effect of SARS-CoV-2 variant emergence on efficacy of neutralizing antibodies and vaccines

A review article focuses on the efficacy of neutralizing antibodies and vaccines against the SARS-CoV-2 variants.

9 Dec 2021

Virus News and Research

Latest Virus News and Research

Study finds mutational changes in Omicron variant likely increase transmissibility

Mutational landscape of SARS-CoV-2 Omicron variant

Screening FDA-approved compounds shown to possess antiviral or antimicrobial activity for SARS-CoV-2 inhibition

Research suggests targeting fusion peptide-calcium interaction may help treat COVID-19

Study finds sarbecoviruses circulating in wildlife outside Asia can infect human cells

Maternal and neonatal cord-blood antibody profile in response to SARS-CoV-2

Neutralizing antibody response against SARS-CoV-2 variants in health care workers pre- and post-vaccination

Insight into immune cell communication may pave the way for new cancer vaccines

Analysis finds substantially more mutations in the omicron SARS-CoV-2 variant

Researchers review transmission, origin, pathogenesis, animal model and diagnosis of Zika virus

Booster vaccination can reduce breakthrough infection risk in HIV patients

Assessing the risk of Omicron variant transmission by travelers from South Africa

COVID-19 vaccine-related myocarditis in young people is mild and resolves quickly, research says

SARS-CoV-2 Omicron variant may bind with ACE2 receptor more efficiently

Investigational mRNA-based HIV vaccine shows promise in mice and non-human primates

KHN’s ‘What the Health?’: Much ado about (vaccine) mandates

Novel waveform-based approach to determine the propensity of betacoronaviruses to infect humans

Study of individuals referred to a cardiovascular disease clinic designed for patients with long COVID

Study reveals the role of intracellular receptor PQBP1 in response to Tau protein

Effect of SARS-CoV-2 variant emergence on efficacy of neutralizing antibodies and vaccines

A new way of characterising biomolecules eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in